This intervention results in a reduced abundance of granulocytic myeloid-derived suppressor cells (G-MDSCs) and M2-like tumor-associated macrophages (TAMs), thereby triggering an anti-tumor response from CD8+ T cells (37). Here, CD8A is linked to neoplasm.